Search results
15 mar 2023 · The primary aim in treating esophageal varices is to prevent bleeding. Bleeding esophageal varices are life-threatening. If bleeding occurs, treatments are available to try to stop the bleeding.
15 mar 2022 · These Clinical Practice Guidelines have been developed to pro-vide practical guidance on debated topics, including current views on haemostasis in liver disease, controversy regarding the need to correct thrombocytopenia and abnormalities in the coagulation system in patients undergoing invasive procedures,
7 cze 2024 · The spectrum of MASLD includes steatosis, metabolic dysfunction-associated steatohepatitis (MASH, previously NASH), fibrosis, cirrhosis and MASH-related hepatocellular carcinoma (HCC). This joint EASL-EASD-EASO guideline provides an update on definitions, prevention, screening, diagnosis and treatment for MASLD.
Ideally, the strategy of management of patients with decompensated cirrhosis should be based on preventing cirrhosis progression (i.e. further decompensation) rather than treating complications as they occur.
17 cze 2022 · These Clinical Practice Guidelines have been developed to provide practical guidance on debated topics including diagnostic methods, prognostic assessment, early detection of complications, optimal care pathways and therapeutic (pharmacological, hamartomas, polycystic liver disease, Caroli disease, Caroli syndrome, biliary hamartomas and ...
Herein we review the pathophysiology of portal hypertension in patients with cirrhosis of the liver and discuss, in particular, the management of the major consequence of portal hypertension—variceal hemorrhage.
1 sty 2024 · AASLD Practice Guidance on the use of TIPS, variceal embolization, and retrograde transvenous obliteration in the management of variceal hemorrhage Hepatology . 2024 Jan 1;79(1):224-250. doi: 10.1097/HEP.0000000000000530.
